BRITTANY BROWN: Open Payments
NPI 1477070399 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,725 in 80 payments from 19 companies in 2025. Trend: 2023 $127 · 2024 $376 · 2025 $1,725
Food & beverage: $1,550Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $311 |
| Alexion Pharmaceuticals, Inc. | 2 | $197 |
| UCB, Inc. | 10 | $183 |
| Lundbeck LLC | 7 | $173 |
| PFIZER INC. | 12 | $171 |
| Eisai Inc. | 4 | $121 |
| Biogen, Inc. | 5 | $115 |
| Axsome Therapeutics, Inc. | 4 | $111 |
| Lilly USA, LLC | 3 | $53 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $44 |
Products named: Leqembi, ULTOMIRIS, VYEPTI, NURTEC ODT, BOTOX, UBRELVY, Symbravo, Briviact.
Industry payments across AL — which companies pay providers there.
